| Literature DB >> 30396356 |
Shuang Leng1, Ru-San Tan1,2, Xiaodan Zhao1, John C Allen2, Angela S Koh1,2, Liang Zhong3,4.
Abstract
BACKGROUND: Abnormal left atrial (LA) function is a marker of cardiac dysfunction and adverse cardiovascular outcome, but is difficult to assess, and hence not, routinely quantified. We aimed to determine the feasibility and effectiveness of a fast method to measure long-axis LA strain and strain rate (SR) with standard cardiovascular magnetic resonance (CMR) compared to conventional feature tracking (FT) derived longitudinal strain.Entities:
Keywords: Cardiovascular magnetic resonance; Left atrial function; Strain; Strain rate
Mesh:
Year: 2018 PMID: 30396356 PMCID: PMC6219067 DOI: 10.1186/s12968-018-0496-1
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Left atrial (LA) strain and strain rate measurement in 4- and 2-chamber views. Left figures show an example of LA feature tracking and strain and strain rate profiles (Endo GLS: endocardial global longitudinal strain). Right figures show the fast long-axis strain and strain rates. White squares denote the three anatomical reference points that were tracked automatically throughout the cardiac cycle. D is the distance between the left atrioventricular junction and the user-defined point at the mid posterior LA wall on standard CMR 4-chamber (denoted as Dseptal and Dlateral) and 2-chamber (denoted as Danterior and Dinferior) views. Fast strain was derived from time variation of distance D. Strain rate was then obtained by taking the first-order derivative of the strain curve. The fast strain and strain rate curves on the right side are based on averaging the results from septal and lateral walls for 4-chamber view and from anterior and inferior walls for 2-chamber view, respectively. Reservoir strain (ε) and strain rate (SRs) correspond to reservoir function. Conduit strain (ε) and strain rate (SRe) correspond to conduit function. Booster strain (ε) and strain rate (SRa) correspond to booster pump function. Details see text
Baseline demographic and clinical characteristics of study subjects
| Variables | Normal Controls ( | HCM ( | HFpEF ( | HFmrEF ( | HFrEF ( |
|---|---|---|---|---|---|
| Age, years | 56 ± 13 | 55 ± 14 | 62 ± 11 | 57 ± 10 | 56 ± 10 |
| Gender, Male/Female | 34/16 | 15/15 | 23/7 | 20/10 | 29/11 |
| BSA, m2 | 1.7 ± 0.2 | 1.8 ± 0.3 | 1.8 ± 0.2 | 1.9 ± 0.2 | 1.8 ± 0.3 |
| DBP, mmHg | 78 ± 10 | 76 ± 10 | 81 ± 24 | 76 ± 12 | 73 ± 14 |
| SBP, mmHg | 135 ± 18 | 137 ± 18 | 142 ± 26 | 134 ± 22 | 122 ± 19*#$ |
| NYHA class | 1.0 ± 0.0 | 1.2 ± 0.4 | 1.6 ± 0.5*# | 1.8 ± 0.7*# | 2.1 ± 0.9*#$ |
| NT-pro-BNP, pg/mLa | – | – | 229 (113, 608) | 479 (304, 781)$ | 2079 (807, 4930)$^ |
| Presence of MR (%) | 0 (0%) | 7 (23%)* | 6 (20%)* | 15 (50%)* | 24 (60%)*#$ |
| Medications (%) | |||||
| Diuretics | 0 (0%) | 6 (20%)* | 21 (70%)*# | 23 (77%)*# | 39 (98%)*# |
| ACE inhibitor/angiotensin receptor blocker | 0 (0%) | 14 (47%)* | 24 (80%)*# | 22 (73%)*# | 29 (73%)*# |
| β-Blocker | 0 (0%) | 24 (80%)* | 23 (77%)* | 20 (67%)* | 36 (90%)* |
| Aspirin | 0 (0%) | 11 (37%)* | 17 (57%)* | 15 (50%)* | 20 (50%)*# |
| LV EDV index, ml/m2 | 70 ± 11 | 76 ± 26 | 78 ± 16 | 87 ± 19* | 138 ± 35*#$^ |
| LV ESV index, ml/m2 | 26 ± 6 | 23 ± 16 | 34 ± 8* | 50 ± 11*#$ | 105 ± 35*#$^ |
| LV SV index, ml/m2 | 45 ± 8 | 53 ± 15* | 44 ± 9# | 38 ± 9# | 33 ± 11*#$ |
| LV EF, % | 64 ± 6 | 72 ± 12* | 56 ± 4*# | 44 ± 3*#$ | 26 ± 8*#$^ |
| LV Mass index, g/m2 | 48 ± 10 | 91 ± 23* | 85 ± 39* | 63 ± 19*# | 82 ± 21* |
| LA volume index | |||||
| Max, ml/m2 | 36 ± 8 | 43 ± 11* | 41 ± 12* | 44 ± 20* | 55 ± 16*#$^ |
| Diastasis, ml/m2 | 26 ± 5 | 33 ± 9* | 34 ± 11* | 37 ± 18* | 47 ± 15*#$^ |
| Min, ml/m2 | 15 ± 4 | 22 ± 6* | 22 ± 8* | 28 ± 19* | 40 ± 16*#$^ |
| LA EF | |||||
| Total, % | 59 ± 5 | 51 ± 7* | 48 ± 7* | 40 ± 13*#$ | 29 ± 13*#$^ |
| Passive, % | 27 ± 7 | 24 ± 7 | 19 ± 7* | 19 ± 7* | 14 ± 6*#$^ |
| Active, % | 43 ± 8 | 36 ± 7* | 36 ± 8* | 26 ± 11*#$ | 17 ± 11*#$^ |
Data are represented as mean ± SD (or amedian (interquartile range)). BSA body surface area, DBP diastolic blood pressure, SBP systolic blood pressure, NYHA New York Heart Association, MR mitral regurgitation, LV left ventricular, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, LVEF left ventricular ejection fraction, LA left atrial, LAEF left atrial emptying fraction, HCM hypertrophic cardiomyopathy, HFpEF heart failure with preserved ejection fraction, HFmrEF heart failure with mid-range ejection fraction, HFrEF heart failure with reduced ejection fraction, *significant difference compared to controls, #significant difference compared to HCM, $significant difference compared to HFpEF, ^significant difference compared to HFmrEF. aNT-pro-BNP results were not available for controls and HCM; NT-pro-BNP results were available in 20 HFpEF and 20 HFmrEF patients
Fig. 2Representative examples of fast LA strain and strain rate in normal control, HCM, HFpEF, HFmrEF and HFrEF
Comparison of fast left atrial strain (ε) and strain rate (SR) measurements among subject groups
| Parameters | Normal Controls ( | HCM ( | HFpEF ( | HFmrEF ( | HFrEF ( |
|---|---|---|---|---|---|
| Left atrial longitudinal strain | |||||
| Reservoir | 35.3 ± 5.2 | 27.0 ± 4.8* | 23.8 ± 4.5*# | 18.8 ± 6.6*#$ | 12.0 ± 5.8*#$^ |
| Conduit | 18.1 ± 4.3 | 12.1 ± 4.3* | 9.6 ± 3.2*# | 8.6 ± 3.4*# | 6.1 ± 3.1*#$^ |
| Booster | 17.2 ± 3.5 | 14.9 ± 3.5* | 14.2 ± 3.7* | 10.2 ± 4.9*#$ | 6.0 ± 3.8*#$^ |
| Left atrial longitudinal strain rate | |||||
| Reservoir SRs, 1/s | 1.8 ± 0.4 | 1.3 ± 0.3* | 1.1 ± 0.2*# | 0.9 ± 0.3*#$ | 0.6 ± 0.2*#$^ |
| Conduit SRe, 1/s | −2.0 ± 0.5 | −1.1 ± 0.4* | −0.9 ± 0.3*# | −0.8 ± 0.3*# | −0.6 ± 0.3*#$^ |
| Booster SRa, 1/s | −2.3 ± 0.6 | −1.8 ± 0.4* | −1.7 ± 0.3* | −1.2 ± 0.5*#$ | − 0.7 ± 0.4*#$^ |
Data are represented as mean ± SD. HCM: hypertrophic cardiomyopathy, HFpEF heart failure with preserved ejection fraction, HFmrEF heart failure with mid-range ejection fraction, HFrEF heart failure with reduced ejection fraction, *significant difference compared to controls, #significant difference compared to HCM, $significant difference compared to HFpEF, ^significant difference compared to HFmrEF
Correlation of left atrial volumetric measurements and corresponding fast strain and strain rate parameters
| Phases | Strain/SR | Volumetric measurements | Correlation coefficient | |
|---|---|---|---|---|
| Reservoir |
| Total LAEF | 0.92 | < 0.0001 |
| SRs | Total LAEF | 0.83 | < 0.0001 | |
| Conduit |
| Passive LAEF | 0.83 | < 0.0001 |
| SRe | Passive LAEF | −0.76 | < 0.0001 | |
| Booster pump |
| Active LAEF | 0.88 | < 0.0001 |
| SRa | Active LAEF | −0.84 | < 0.0001 |
ε left atrial strain, SR left atrial strain rate, LAEF left atrial emptying fraction
Fig. 3The effect of NYHA class on the fast LA strain in patient groups (HCM, HFpEF, HFmrEF, HFrEF). *p < 0.05 vs. NYHA I; #p < 0.05 vs. NYHA II
Fig. 4The effect of mitral regurgitation (MR) on the fast LA strain in patient groups (HCM, HFpEF, HFmrEF, HFrEF). *p < 0.05 vs. patients without MR
Fig. 5Correlation between fast LA phasic strain (left column)/strain rate (right column) and Ln NT-proBNP level in heart failure patients. Note here that absolute values of SRe and SRa were used in the correlation analysis. *NT-proBNP results were available in 20 HFpEF and 20 HFmrEF patients
Fig. 6Correlation plots for the fast strain (left column) and strain rate (right column) compared with feature tracking (FT) derived measurements. Blue solid line and black dash lines denote Passing Bablok non parametric regression line and 95% confidence interval, respectively. Red dot line denotes equality line
Fig. 7Bland-Altman plots for the fast LA strain (left column) and LA strain rate (right column) compared with feature tracking (FT) derived measurements. The bias (solid line) and limits of agreement (dash lines) are shown in each graph
Utility of fast left atrial strain and strain rate parameters, as well as volumetric measurements to differentiate patients with HCM, HFpEF and HFmrEF from controlsa
| Variables | AUC | Sensitivity | Specificity | Threshold |
|---|---|---|---|---|
| Reservoir function | ||||
| Fast reservoir |
|
|
|
|
| Fast reservoir SRs, 1/s | 0.93 | 0.76 | 0.98 | 1.26 |
| FT reservoir | 0.90 | 0.82 | 0.88 | 26.7 |
| FT reservoir SRs, 1/s | 0.84 | 0.80 | 0.80 | 1.24 |
| Total LAEF, % | 0.88 | 0.68 | 0.96 | 51.1 |
| Conduit function | ||||
| Fast conduit | 0.92 | 0.76 | 0.96 | 12.4 |
| Fast conduit SRe, 1/s |
|
|
|
|
| FT conduit | 0.91 | 0.82 | 0.86 | 14.3 |
| FT conduit SRe, 1/s | 0.93 | 0.82 | 0.96 | −1.14 |
| Passive LAEF, % | 0.76 | 0.75 | 0.74 | 24.3 |
| Booster pump function | ||||
| Fast booster | 0.79 | 0.80 | 0.66 | 15.6 |
| Fast booster SRa, 1/s |
|
|
|
|
| FT booster | 0.76 | 0.65 | 0.84 | 14.3 |
| FT booster SRa, 1/s | 0.77 | 0.88 | 0.58 | −1.94 |
| Active LAEF, % | 0.78 | 0.80 | 0.68 | 39.3 |
aResults of the receiver operating characteristic (ROC) analysis with area under the curve (AUC), sensitivity, specificity and threshold. ε left atrial strain, SR left atrial strain rate, FT feature tracking, LAEF left atrial emptying fraction. Italic values indicate the best predictors of phasic LA function as determined by AUC
Intra- and inter-observer reproducibility for left atrial strain and strain rate measurements derived by fast and FT approach
| Method | Strain/SR | Intra-observer ( | Inter-observer ( | ||
|---|---|---|---|---|---|
| Bias (limits of agreement) | CV, % | Bias (limits of agreement) | CV, % | ||
| Fast approach | −0.01 (−2.37, 2.34) | 3.6 | −0.15 (−3.16, 2.86) | 4.7 | |
| −0.15 (−1.81, 1.51) | 5.3 | 0.10 (−1.58, 1.77) | 5.3 | ||
| 0.14 (−1.76, 2.04) | 6.2 | −0.25 (−2.93, 2.43) | 8.9 | ||
| SRs, 1/s | 0.03 (−0.18, 0.23) | 6.5 | 0.06 (−0.24, 0.35) | 9.7 | |
| SRe, 1/s | −0.05 (− 0.29, 0.18) | 7.9 | − 0.03 (− 0.29, 0.23) | 8.1 | |
| SRa, 1/s | −0.01 (− 0.25, 0.24) | 6.4 | −0.03 (− 0.38, 0.32) | 9.4 | |
| FT approach | 0.16 (−5.39, 5.72) | 8.6 | 0.21 (−5.29, 5.71) | 8.5 | |
| 0.24 (−2.54, 3.02) | 8.8 | −0.17 (−3.18, 2.84) | 9.5 | ||
| −0.08 (− 3.01, 2.87) | 9.6 | 0.38 (− 3.26, 4.02) | 11.9 | ||
| SRs, 1/s | 0.03 (−0.28, 0.34) | 9.5 | 0.07 (−0.25, 0.39) | 10.0 | |
| SRe, 1/s | −0.06 (− 0.36, 0.25) | 10.3 | 0.08 (− 0.26, 0.42) | 11.4 | |
| SRa, 1/s | −0.03 (− 0.44, 0.37) | 10.6 | − 0.08 (− 0.62, 0.45) | 13.9 | |
ε left atrial strain, SR left atrial strain rate, FT feature tracking, CV coefficient of variation